-
Safety and Efficacy of Flumatinib in Patients with Chronic Phase Chronic Myeloid Leukemia: A Real-Life Cohort Observational Study
21 Jan 2026 15:11 GMT
… Characteristics of Patients with Chronic Myeloid Leukemia
Treatment Response in … TFR eligibility.
Abbreviations
CML, Chronic myeloid leukemia; CP, Chronic-phase; AEs … tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance …
-
<![CDATA[Chronic Myeloid Leukemia: From Diagnosis to Ongoing Management ]]>
18 Jan 2026 19:24 GMT
Receiving a diagnosis of Chronic Myeloid Leukemia (CML) can be frightening, but … How Targeted Therapies Are Transforming Chronic Myeloid Leukemia Care," by Ryan Scott … how-targeted-therapies-are-transforming-chronic-myeloid-leukemia-care
Editor's note …
-
EU Backs Kinase Inhibitor Use in Initial Ph+ ALL Therapy
03 Feb 2026 12:15 GMT
… use in adult patients with chronic myeloid leukemia in chronic, accelerated, or blast …
-
Chronic Myeloid Leukemia Highlights From ASH 2025
30 Dec 2025 21:26 GMT
Key abstracts on chronic myeloid leukemia (CML) treatment from the 2025 …
-
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
02 Feb 2026 21:05 GMT
… convenience of existing treatments for chronic myeloid leukemia. For more information, please visit …
-
Terns Pharmaceuticals, Inc. (TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia Transcript
09 Dec 2025 07:42 GMT
… Update for TERN-701 in Chronic Myeloid Leukemia December 8, 2025 4:30 … evaluated for the treatment of chronic myeloid leukemia or CML. We will discuss …
-
STAT+: At ASH, Terns looks like rival to Novartis with drug for chronic myeloid leukemia
08 Dec 2025 22:44 GMT
Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events.
This is the online version of ASH in 30 Seconds, STAT’s report from the American Society of Hematology …
-
Lupin rolls out generic oncology drug in US market
02 Feb 2026 11:54 GMT
… adults with Philadelphia chromosome-positive chronic myeloid leukemia. The US market for Dasatinib …
-
Lupin launches generic cancer drug in US
02 Feb 2026 11:17 GMT
… with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia in chronic phase.
As per …
-
Targeted Chronic Myeloid Leukemia Drugs Show Divergent Cardiovascular Risk Profiles, JACC Cardio-Oncology State-of-the-Art Review Reports
01 Dec 2025 05:44 GMT
… are frequent in patients with Chronic Myeloid Leukemia (CML). Therefore, it … involving new pharmacological agents.
Chronic Myeloid Leukemia (CML), a myeloproliferative neoplasm … Disease in Patients With Chronic Myeloid Leukemia: JACC: CardioOncology State-of …
About
© 1995-2026